MARILYN DORSEY: Open Payments
NPI 1578028528 · TIFFIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 12 payments from 9 companies in 2025. Trend: 2023 $1,020 · 2024 $330 · 2025 $321
Food & beverage: $171Education: $150
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Lundbeck LLC | 1 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| ABBVIE INC. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: INGREZZA, REXULTI, COBENFY, SPRAVATO, INVEGA SUSTENNA, VRAYLAR, FANAPT, ARISTADA.
Industry payments across OH — which companies pay providers there.
